The Pharmacokinetics and Effectiveness of Local LevoBupivacaine Injection on Primary Total Joint Replacement Model.
Arthropathy
About this trial
This is an interventional treatment trial for Arthropathy focused on measuring Local analgesia, Pharmacokinetics, Total joint replacement
Eligibility Criteria
Inclusion Criteria:
- Primary total joint replacement, no previous open surgery on the same joint
- Age 50~80 y/o, Pre-operative diagnosis: degenerative osteoarthritis
- Pre-operative deformity: varus <15°, valgus <15°, flexion contracture <15°.
- Patients with normal heart function
- Willing to receive post-operative questionnaire and outpatient clinic follow-up
Exclusion Criteria:
- Allergy to Patient-Controlled Analgesia or LevoBupivacaine
- Mental or cognitive illness that couldn't well response to questionnaire
- American Society Anesthesiologist more than III degree
- Liver cirrhosis, chronic renal insufficiency, heart disease or arrhythmia, insulin-dependent diabetes mellitus, and previous narcotic abuse history.
- Not suitable for using patient-controlled analgesia pump by evaluation of anesthesiologist
Sites / Locations
- Chang Gung Memorial Hospital, Linkou
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Active Comparator
Experimental
Patient-Controlled Analgesia
Peri-articular LevoBupivacaine
Intra-articular LevoBupivacaine
Patient had no local analgesic agent during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.
Patient had periarticular local analgesic agent, LevoBupivacaine Hydrochloride, during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.
Patient had intra-articular local analgesic agent, LevoBupivacaine Hydrochloride, during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.